Notice NOT-DA-21-043 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-245 from the NIH Guide for Grants and Contracts

Notice NOT-HG-21-024 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-225 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-187 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Mentoring Activities

The answer is more complicated than you might expect, our Experimental Error columnist writes

£45,516-£54,524: Wellcome Sanger Institute: The Opportunity: Are you a Principal Bioinformatician with a passion for genomics who would like to improve the prevention and treatment of skin ca... Hinxton, Cambridgeshire

Competitive Salary: EMBL: About this position A highly motivated, Python Software developer is wanted to help implement the next-generation of genome-scale Ensembl processin Hinxton, Cambridgeshire, England

Funding Opportunity PAR-21-196 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that complement and/or enhance the training of a diverse workforce to meet the nations biomedical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on skills development, mentoring, and outreach to equip a diverse cohort of participants with the technical, operational, and professional skills required for careers in the biomedical research workforce. Funded programs are expected to have robust evaluation, dissemination, and sustainability plans.

Funding Opportunity RFA-AR-21-016 from the NIH Guide for Grants and Contracts. Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed)

Funding Opportunity RFA-AR-21-015 from the NIH Guide for Grants and Contracts. Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional)

Notice NOT-AI-21-042 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-21-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research applications to support the understanding of how HIV RNA chemical modifications impact expression of intact and defective HIV and the identification of potential therapeutic targets for future HIV cure strategies.

Notice NOT-DA-21-014 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-22-010 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage the small business community to collaborate with scientists and clinicians in the fields of female and male reproductive medicine, infertility, andrology/urology, and gynecology to develop, adapt and validate discoveries in genomics, epigenomics, metabolomics and biomarkers to the clinical diagnosis and treatment of women and men with infertility, and diseases and disorders that affect fertility. The ultimate goal is to advance the application of precision medicine to reproductive health through the development of new procedures, assays, digital apps, devices or technologies that improve the specificity, accuracy and rapidity of diagnosis and enhance the individualization, safety and convenience of clinical care.

Funding Opportunity PA-21-201 from the NIH Guide for Grants and Contracts. Reissue of the PA-18-401. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD).

Funding Opportunity PA-21-200 from the NIH Guide for Grants and Contracts. Reissue of the PA-18-400. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD).

Funding Opportunity PA-21-199 from the NIH Guide for Grants and Contracts. Reissue of the PA-18-399. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD). An R03 grant supports small, discrete, well-defined projects that can be completed in two years and that require limited resources. An R03 grant application may not contain extensive detail or discussion. R03 applications may include development of new research methodologies or technology, secondary analysis of existing data, and pilot or feasibility studies. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies.

Funding Opportunity RFA-AI-21-025 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support projects to improve use of evidence-based HIV prevention interventions among populations in jurisdictions identified as highly impacted by HIV. Research funded under this initiative will support the goals of the DIAGNOSE and PREVENT pillars of the Ending the HIV Epidemic: A Plan for America (EHE) initiative towards reducing HIV incidence. Creative, multidisciplinary approaches are needed to meet the needs of specific populations and localities.

Funding Opportunity RFA-AI-21-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to utilize implementation science to develop, implement, and evaluate creative, multidisciplinary approaches to healthcare delivery that more effectively engage and retain individuals in HIV care and treatment so that they achieve durable viral suppression. Research funded under this initiative will support the goals of the DIAGNOSE and TREAT pillars of the Ending the HIV Epidemic: A Plan for America (EHE) initiative by seeking to achieve more rapid and sustained viral suppression and improved outcomes for people living with HIV (PLWH) through better healthcare engagement.